cmTriage

by CureMetrix  · Based in United States → — AI-Powered Mammography BAC Detection, Quantification, and Contextualization
Oncology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Regulatory Status Disclosed

Overview

CureMetrix cmTriage is an FDA-cleared artificial intelligence (AI) tool designed for mammography workflow optimization. It is intended for radiologists in various care settings, including independent radiology practices, hospital systems, and large imaging centers. The software integrates into existing Picture Archiving and Communication Systems (PACS) workflows.

cmTriage functions by analyzing 2D full-field digital mammograms (FFDM) and flagging cases that suggest the presence of suspicious findings. This allows radiologists to prioritize their mammogram worklist, moving potentially critical cases to the top for immediate review. The system provides a passive notification triage code to the radiologist’s worklist.

Notable capabilities include its ability to work across all breast densities and with both masses and calcifications. It is designed to help radiologists organize their worklist and focus on cases requiring more immediate attention. The software is delivered as a cloud-based, Software-as-a-Service (SaaS) solution.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-based triage for mammography worklists
  • Prioritizes suspicious cases for immediate attention
  • Optimizes radiologist workflow and efficiency
  • Compatible with most screening mammography equipment
  • Cloud-based deployment with no added systems to install
  • DICOM compliant for seamless integration
  • Works across all breast densities
  • Identifies both mass and calcifications
  • Potential to help radiologists read mammograms up to 30-40% faster
  • High accuracy with an Area Under the Curve (AUC) of 0.95

Use Cases

  • Prioritizing mammography worklists for radiologists
  • Flagging suspicious cases that may need immediate attention
  • Optimizing clinical protocols and maximizing clinic resource utilization
  • Strategically distributing mammograms to multiple readers or specialists
  • Expediting callback reports and patient workups
  • Improving breast cancer detection rates

What Physicians Need to Know

Key Capabilities
cmTriage is an AI-based software solution designed to triage, sort, and prioritize mammography worklists. It identifies and flags suspicious cases for immediate radiologist review, helping to optimize workflow and reduce turnaround time for critical cases. The software works across all breast densities and can identify both masses and calcifications.
Clinical Utility
The tool helps radiologists prioritize their worklist, allowing them to focus on suspicious cases first and potentially read normal exams faster. Studies have shown that using cmTriage can lead to up to 30% faster reading times for radiologists. It can also help reduce backlogs in screening mammograms and optimize the distribution of mammograms among multiple readers in a large practice.
Integration Options
cmTriage integrates directly into existing PACS systems and is PACS agnostic. It is also available on the Nuance AI Marketplace, providing workflow-integrated access within the Nuance PowerScribe radiology reporting platform.
Compliance Status
cmTriage is the first FDA-cleared AI-based triage solution for mammography in the U.S. It received FDA 510(k) clearance (K183285) on March 8, 2019. The solution is HIPAA and DICOM compliant.
Pricing Model
During the COVID-19 crisis, CureMetrix waived all installation costs for cmTriage. No other specific pricing model details are available.
User Experience
The software is fully automatic and cloud-based, requiring no new hardware installation. Training can be completed online in minutes. Radiologists can customize, sort, and prioritize their mammography worklist. The tool provides a passive notification within the PACS worklist, indicating suspicious cases.
Support Quality
CureMetrix offers implementation resources, educational materials, hands-on support, technical documentation, useful guides, FAQs, and an insights and analytics dashboard.
Implementation Complexity
Implementation is described as fast, easy, and secure, with no hardware to install or software to integrate. The cloud-based nature of the solution allows for quick deployment.
Evidence Base
cmTriage has an area under the curve (AUC) of 0.95. Studies have shown that cmTriage can lead to improved diagnostic performance and workload reduction. In one study, it correctly classified 1,138 of 2,129 confirmed normal mammograms as low suspicion, potentially reducing the need for double reading by 53%. The software operates with a high specificity, indicating a low rate of incorrectly marked "suspicious" cases. Research validating CureMetrix AI solutions, including cmTriage, has been presented at major radiology conferences.
Physician Tip

cmTriage can significantly enhance workflow efficiency by intelligently prioritizing mammograms, allowing for immediate focus on potentially critical cases. This can lead to faster reading times and reduced radiologist burnout. It's important to remember that cmTriage is a prioritization tool and does not provide diagnostic information beyond triage; full patient evaluation remains the radiologist's responsibility. The ability to sort and customize worklists can be particularly beneficial in practices with high volumes or multiple readers.

cmTriage is designed for seamless integration with existing PACS and is available through the Nuance AI Marketplace, offering a streamlined experience within common radiology reporting platforms. Its cloud-based architecture and DICOM compliance facilitate easy setup and data handling.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentCloud-based. It integrates with existing PACS systems.
TrainingUnknown
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Oncology, Radiology

Support & Reliability

Training ProvidedUnknown

What the Web Says

cmTriage is an FDA-cleared AI-based software designed to optimize mammography workflow by prioritizing suspicious cases for radiologists. It aims to improve efficiency, reduce reading times, and enhance the accuracy of breast cancer detection. Studies suggest that radiologists using cmTriage can achieve faster reading times and improved diagnostic performance.

Overall: Positive

Strengths

  • Prioritizes suspicious mammograms, allowing radiologists to focus on critical cases first.
  • Can reduce mammogram reading time by approximately 30%.
  • Increases radiologist sensitivity and overall accuracy in breast cancer detection.
  • Reduces false recall rates by up to 34%, saving patient and clinic time and resources.
  • Works across all breast densities and with both masses and calcifications.
  • Integrates with existing PACS systems.

Limitations

  • Does not provide diagnostic information beyond triage and prioritization.
  • Should not be used in lieu of full patient evaluation or relied upon to make or confirm a diagnosis.
  • At a default sensitivity of 93%, it may incorrectly mark a percentage of normal cases as suspicious.
  • No specific negative reviews from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra were found.
  • Limited information available from independent review platforms like G2 or Capterra specifically for cmTriage by CureMetrix.

Based on reviews from: curemetrix.com, auntminnie.com, thesiliconreview.com, theicecommunity.com, einpresswire.com, radiologybusiness.com, appliedradiology.com, fda.gov, innolitics.com, preprints.org, sourceforge.net, g2.com

Last updated: 2026-10-29

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate cmTriage

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

einpresswire.com
CureMetrix® receives FDA Clearance for AI-based triage software for mammography
CureMetrix announced on March 19, 2019, that it received FDA clearance for its AI-based software, cmTriage, which helps radiologists prioritize mammography worklists by highlighting cases that may require immediate attention. The company states that cmTriage has an area under the curve (AUC) of 0.95, indicating high efficacy in identifying suspicious cases without excessive false positives.
2019-03
auntminnie.com
CureMetrix adds cmTriage to Nuance AI Marketplace
CureMetrix announced on May 28, 2020, that its FDA-cleared cmTriage software would be available on the Nuance AI Marketplace. The software is designed to triage, sort, and prioritize mammography worklists based on cases needing immediate attention, with studies suggesting up to a 30% faster reading time for radiologists.
2020-05
curemetrix.com
CureMetrix recognized by Fast Company
On October 5, 2020, CureMetrix was recognized as a finalist in Fast Company's Innovation by Design Awards for 2020 in the Health category for its cmTriage™ product. cmTriage is highlighted as the first FDA-cleared AI-based triage solution for mammography in the U.S., capable of reducing mammography reading time by up to 30%.
2020-10
curemetrix.com
AI Test Drive - CureMetrix Highlights Mammo AI Study Results
CureMetrix reported at the virtual RSNA 2020 meeting that radiologists using its AI software, including cmTriage for worklist prioritization, showed improved accuracy and faster reading times for normal exams. A 'Test Drive Challenge' study demonstrated that radiologists using AI had a 5% improvement in sensitivity and 34% in specificity, and read normal exams 40% faster.
2020-12
curemetrix.com
New Research Confirms Impact of CureMetrix AI on Improving Breast Cancer and Heart Disease Detection
On May 17, 2021, CureMetrix presented research at major radiology conferences highlighting the value of cmTriage and other AI solutions for mammography. The company stated that cmTriage, the first FDA-cleared AI-based triage software in the U.S., can help radiologists read mammograms 30 percent faster by prioritizing suspicious cases.
2021-05
prnewswire.com
Novarad Partners with CureMetrix to Advance AI-Driven Mammography
Novarad announced a partnership with CureMetrix on November 28, 2021, to distribute CureMetrix's AI-driven women's health suite, including cmTriage, nationally in the U.S. CureMetrix's FDA-cleared cmTriage is an application that prioritizes suspicious cases directly into the radiology worklist, aiming to streamline workflow and improve early cancer detection.
2021-11
einpresswire.com
CureMetrix Receives ISO 13485:2016 Certification for Artificial Intelligence (AI) Based Mammography Software
On August 2, 2022, CureMetrix announced it received ISO 13485:2016 certification for Quality Management Systems, which will help bring its AI-based digital mammography solutions, including cmTriage, to a global market. cmTriage is described as the first FDA-cleared software designed to provide a notification triage code to a radiologist's mammography worklist based on suspicious findings.
2022-08
oup.com
Multicenter, Multivendor Validation of an FDA-approved Algorithm for Mammography Triage
A study published in the Journal of Breast Imaging on October 15, 2022, validated the cmTriage algorithm for mammography triage, showing an AUC of 0.95 for case identification. The study analyzed anonymized images using cmTriage to flag exams as 'suspicious' or not, with consistent results across different breast densities and lesion types.
2022-10

Videos

Product demos, reviews, and walkthroughs for cmTriage.

View all on YouTube

Frequently Asked Questions

cmTriage is designed to integrate seamlessly into your existing PACS and is cloud-based, meaning no new hardware or complex software integration is typically required. Its primary use is to prioritize mammography worklists by flagging suspicious cases, allowing radiologists to focus on those cases first and potentially read mammograms up to 30-40% faster. This helps streamline workflow and can assist in managing backlogs.
cmTriage is the first FDA-cleared AI-based triage solution for mammography in the U.S. and is also ANVISA approved in Brazil. It is HIPAA and DICOM compliant, and also adheres to ISO 13485 and MDSAP compliance standards.
While cmTriage can significantly improve efficiency and aid in detection, it is a triage tool that flags suspect mammograms for closer review by radiologists, rather than providing a definitive diagnosis. It helps prioritize cases and can increase cancer detection rates, but like all AI tools, it should be viewed as a support tool and not a replacement for clinician judgment. The software's sensitivity can be adjusted, with higher sensitivity potentially leading to more false positives.
While cmTriage was the first FDA-cleared AI-based triage solution for mammography in the U.S., other AI solutions exist in the market, such as MedCognetics' QmTRIAGE, which also received FDA 510(k) clearance for breast cancer screening. Specific comparative data on performance against direct competitors is not readily available, but cmTriage has demonstrated the ability to help radiologists read mammograms up to 40% faster and has an accuracy measure of 0.95 "area under the curve" ratio.
The cost for cmTriage is expected to be in the range of $1 to $5 per mammogram. This pricing is designed to be cost-effective, with the aim of reducing healthcare costs for both providers and patients by increasing efficiency and enabling earlier diagnoses. Specific comparisons to other AI solutions are not available, but the company has waived installation costs during certain periods to support practices.

Related Tools

SOPHiA DDM
SOPHiA GENETICS
Oncology AI
SOPHiA DDM™ is an AI-driven and cloud-powered platform that helps clinicians generate real-time, actionable insights for patients with cancer and rare disorders by analyzing complex genomic, radiomic, and multimodal data.
Paid
CerviCARE AI
NTL Healthcare
OB/GYN AI
CerviCARE AI is an AI-powered cervical cancer screening system that analyzes smartphone images of the cervix to predict findings, aiming for early detection.
Lumonus AI
Lumonus
Clinical Decision Support & Reference
Lumonus AI is an AI-powered software that assists healthcare providers with prescriptions, dosing, and treatment for cancer patients, with a module (Sigma) that suggests treatment protocols based on prior plans for similar patients.
DeepBio DeepDx® Prostate
DeepBio
Oncology AI
DeepDx® Prostate leverages deep learning to standardize prostate cancer diagnostics by detecting abnormalities in digital slides with high precision, providing automated Gleason grading, tumor quantification, and tumor length measurements.
AIRA Matrix AI Solutions
AIRA Matrix
Lab & Diagnostics
AIRA Matrix offers AI solutions to improve efficiency and diagnostic accuracy in pathology lab workflows, primarily for prostate and breast cancer, with services like DPaaS and predictive toxicology.
Surgical Reality Viewer
Surgical Reality
Oncology AI
Surgical Reality offers CE- and FDA-certified AI-powered 3D medical imaging and surgical planning software that transforms CT scans into patient-specific 3D models for thoracic surgery, enhancing precision in complex lung procedures.

See all Oncology AI tools →

More from CureMetrix

cmAngio®
CureMetrix
Cardiology AI
cmAngio® by CureMetrix is FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment.
Paid, out-of-pocket

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-18 | First Added: 2026-04-18

Investors who backed cmTriage

Funded through the company that built this tool.

Keshif Ventures
Family Office T3
San Diego, United States
$1M-$5M
Keshif Ventures is a Pittsburgh-based early-stage venture firm investing in software and technology companies across enterprise SaaS, fintech, and selectively healthcare, with…
Biotech Digital Health
AI Tool Finder
AI-powered search. Results may not be comprehensive.